Seiji Yano

17PUBLICATIONS
78CO-AUTHORS
Molecular targetsPredictive and prognostic markersGene and molecular therapyOtorhinolaryngologyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jan 18, 2026
Therapeutic Strategies to Overcome Payload Resistance of Trastuzumab Deruxtecan in HER2-Positive Cancers.

Yuya Murase, Shigeki Nanjo, Sachiko Arai

|Nov 25, 2025
Waiting periods for the initiation of cancer treatment and the factors associated with delays in the Hokushin region of Japan.

Yutaro Takahashi, Yoshikazu Nishino, Tomoya Takiguchi

|Nov 09, 2025
MET Enhances Amivantamab Binding to EGFR and Antibody-Dependent Cellular Toxicity.

Shigeki Sato, Neval Yilmaz, Sachiko Arai

|Nov 04, 2024
YAP Regulates HER3 Signaling-Driven Adaptive Resistance to RET Inhibitors in RET-Aberrant Cancers.

Yuki Katayama, Tadaaki Yamada, Keiko Tanimura

Pageof 3